Experience
Represented Japan’s leading manufacturer of industrial boilers on it’s acquisition of a U.S. based producer of boilers, burners, and industrial boilers (2024).
Represented an international data center developer as majority partner in a Japanese joint venture to establish Asia’s largest data center (2020).
Represented Japan’s leading e-commerce and online retail platform in multiple transactions, including the simultaneous acquisition of telecom service providers in India and the United States (2020), a joint venture project (2020), an advertising joint venture (2019), a UAV traffic control joint venture (2018), and 10+ venture capital investments (2014-2018).
Represented a global pharmaceutical company (one of the top 5 by size globally) in multiple transactions, including several separate licensing and manufacturing collaborations (2017-2020), a share and asset sale/disposal (2018), and a joint venture formation (2012).
Represented Europe’s largest natural cosmetics brand in the acquisition of an own-brand Japan business (involving 100+ individual retail locations in Japan) (2020).
Represented a listed Japanese beverage producer (one of Japan’s biggest brewers (listed)) in 10+ transactions, including the successful auction sale of a major subsidiary, the acquisition and buyout of a Japan-based joint venture, the acquisition of a U.S. company, collaborations with U.S. soft drink manufacturers and U.S. beer manufacturers, and others (2012-2020).
Represented a listed Japanese trading house in 15+ separate M&A and joint venture transactions across Asia, Europe, and the Americas (industries include renewable energy, power, retail, and natural resources) (2012-2020).
Represented another listed Japanese trading house in several separate acquisitions and joint ventures in the metals industry (2011, 2013, 2014, 2020).
Represented a listed Japanese food producer in its successful acquisition of a U.S./Canadian B2B chocolate business (#1 in the Americas, #3 in the world) in a competitive auction (2019).
Represented a listed Japanese pharmaceutical and foods producer in its acquisition of one of the world’s largest cheese alternative food manufacturers (United States and Canada) (2017) in a competitive auction.